SCHEMBL17829166

SCHEMBL17829166

Cc1ccc(-c2cccc(-c3nc(-c4cc(-n5c6ccccc6c6cc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)ccc65)cc(-n5c6ccccc6c6cc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)ccc65)c4)nc4ccc5ccccc5c34)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.38
PTGER4 P35408 1/20 0.36
ALDH1A1 P00352 4/20 0.34
RXFP1 Q9HBX9 2/20 0.34
ATM Q13315 2/20 0.33
NPC1 O15118 2/20 0.33
HTT P42858 2/20 0.33
RAB9A P51151 2/20 0.33
LMNA P02545 2/20 0.33
XBP1 P17861 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
EGFR P00533 1/20 0.33
ERBB2 P04626 1/20 0.33
GAA P10253 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
TP53 P04637 1/20 0.32
NPY5R Q15761 1/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17829192 0.98 PTGES (0.35) PTGESPTGER4ALDH1A1RXFP1ATM
SCHEMBL17829178 0.97 PTGES (0.37) PTGESPTGER4ALDH1A1RXFP1ATM
SCHEMBL17829010 0.95 PTGES (0.39) PTGESPTGER4ALDH1A1ATMNPC1
SCHEMBL17829185 0.94 PTGES (0.35) PTGESPTGER4ALDH1A1ATMNPC1
SCHEMBL17829018 0.92 PTGES (0.39) PTGESPTGER4ALDH1A1ATMNPC1
SCHEMBL17829007 0.92 PTGES (0.40) PTGESPTGER4ALDH1A1ATMNPC1
SCHEMBL17829181 0.91 FLT3 (0.36) ALDH1A1RXFP1ATMNPC1HTT
SCHEMBL17828936 0.91 PTGES (0.39) PTGESPTGER4ALDH1A1ATMNPC1
SCHEMBL17829012 0.91 PTGES (0.41) PTGESPTGER4ALDH1A1ATMNPC1
SCHEMBL17829183 0.90 FLT3 (0.32) PTGESALDH1A1ATMNPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 PTGES 3205/4885PTGER4 3290/4885ALDH1A1 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.